<DOC>
	<DOCNO>NCT01728389</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety direct intrabone transplantation procedure peripheral blood haematopoietic stem cell form HLA-matched sibling donor patient myeloid lymphoid malignancy .</brief_summary>
	<brief_title>Intrabone Transplantation Allogenic Peripheral Blood Stem Cells Patients With Myeloid Lymphoid Malignancies .</brief_title>
	<detailed_description>Allogenic haematopoietic stem cell transplantation establish treatment option haematologic malignancy , especially leukaemias lymphoma , provide curative potential . The optimal donor HLA-matched sibling G-CSF stimulate peripheral blood nowadays common source stem cell . Routinely used route stem cell transplantation intravenous infusion via central venous catheter . Based animal study , 10-15 % intravenously transplanted stem cell migrate haematopoietic site rest lose organ . Results study direct intrabone allogenic cord-blood cell transplantation human confirm route transplantation associate less probability graft failure moreover may reduce risk graft-versus-host disease malignancy relapse . For purpose current study investigate intrabone route allogenic peripheral blood stem cell transplantation . Our intention achieve fast engraftment minimize risk relapse graft graft-versus-host disease .</detailed_description>
	<criteria>Age 1855 year Diagnosis leukaemia lymphoma Indication allogenic stem cell transplantation accord European Group Blood Marrow Transplantation guideline HLAmatched sibling donor qualify peripheral blood stem cell donation Performance status WHO 01 Written inform consent Organ dysfunction : elevated ALT , AST , bilirubin , AF ; creatinine &gt; 1.5 upper normal limit ; LVEF &lt; 45 % Active infection Unstable diabetes Psychiatric disease Obesity anatomical obstacle direct intrabone transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>allogenic stem cell transplantation</keyword>
	<keyword>peripheral blood stem cell</keyword>
	<keyword>intrabone</keyword>
	<keyword>intra-bone</keyword>
	<keyword>leukemia</keyword>
	<keyword>lymphoma</keyword>
</DOC>